<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about SCLN</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Thu, 20 Jun 2013 07:59:10 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=SCLN" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/weekly-preview-fed-in-focus-as-tapering-fears-mount-cm253591">
      <guid isPermaLink="false">253591</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2sNHvZZgOPc/weekly-preview-fed-in-focus-as-tapering-fears-mount-cm253591</link>
      <category>Investing</category>
      <category>Economy</category>
      <category>International</category>
      <category>Investing Ideas</category>
      <category>US Markets</category>
      <title>Weekly Preview: Fed In Focus as Tapering Fears Mount</title>
      <description>Next week, the Fed's policy statement, updated forecasts and Press Conference with Chairman Ben Bernanke will be closely watched. Key earnings from companies including FedEx (NYSE:  FDX  ),&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/2sNHvZZgOPc" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 14 Jun 2013 23:44:40 Z</pubDate>
      <a10:updated>2013-06-19T18:42:10Z</a10:updated>
      <author>Matthew Kanterman</author>
      <nasdaq:tickers>ADBE</nasdaq:tickers>
      <nasdaq:tickers>CEDU</nasdaq:tickers>
      <nasdaq:tickers>CSUN</nasdaq:tickers>
      <nasdaq:tickers>ORCL</nasdaq:tickers>
      <nasdaq:tickers>SCLN</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/weekly-preview-fed-in-focus-as-tapering-fears-mount-cm253591</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/weekly-cfo-sells-highlight-v-scln-vr-amsg-cm150885">
      <guid isPermaLink="false">150885</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m-MaiEwUtTs/weekly-cfo-sells-highlight-v-scln-vr-amsg-cm150885</link>
      <category>Investing</category>
      <title>Weekly CFO Sells Highlight: V, SCLN, VR, AMSG</title>
      <description>According to  GuruFocus Insider Data  , the largest CFO sells during the past week were: Visa Inc., SciClone Pharmaceuticals Inc., Validus Holding Ltd. and Amsurg Corp.   Visa Inc. (  V  ): CFO&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/m-MaiEwUtTs" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 25 Jun 2012 21:10:53 Z</pubDate>
      <a10:updated>2012-06-25T18:11:17Z</a10:updated>
      <author>gurujx</author>
      <nasdaq:tickers>AMSG</nasdaq:tickers>
      <nasdaq:tickers>SCLN</nasdaq:tickers>
      <nasdaq:tickers>V</nasdaq:tickers>
      <nasdaq:tickers>VR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/weekly-cfo-sells-highlight-v-scln-vr-amsg-cm150885</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/insomnia-found-to-cost-63-billion-a-year-here-are-4-companies-to-treat-it-cm97883">
      <guid isPermaLink="false">97883</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WVFnbuxpc3E/insomnia-found-to-cost-63-billion-a-year-here-are-4-companies-to-treat-it-cm97883</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <category>Technology</category>
      <title>Insomnia Found to Cost $63 Billion a Year - Here are 4 Companies to Treat It</title>
      <description>( By Alexander Crawford )  According to a  recent study , insomnia costs the average US worker 11.3 days in productivity (about $2,280) every year, amounting to $63 billion annually. This&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/WVFnbuxpc3E" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 12 Oct 2011 03:09:06 Z</pubDate>
      <a10:updated>2011-10-11T23:09:09Z</a10:updated>
      <author>Kapitall</author>
      <nasdaq:tickers>ALXA</nasdaq:tickers>
      <nasdaq:tickers>NBIX</nasdaq:tickers>
      <nasdaq:tickers>QCOR</nasdaq:tickers>
      <nasdaq:tickers>SCLN</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/insomnia-found-to-cost-63-billion-a-year-here-are-4-companies-to-treat-it-cm97883</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/7-biotech-penny-stocks-to-buy-cm49689">
      <guid isPermaLink="false">49689</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1jnlxFFun34/7-biotech-penny-stocks-to-buy-cm49689</link>
      <category>Investing</category>
      <category>Stocks</category>
      <title>7 Biotech Penny Stocks to Buy</title>
      <description>3 Breakout Stocks Under $5                Biotech stocks are on the rise right now for many reasons. I   recently wrote about the     coming shift out of bonds and into&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/1jnlxFFun34" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 17 Dec 2010 14:11:05 Z</pubDate>
      <a10:updated>2010-12-17T16:04:31Z</a10:updated>
      <author>Louis Navellier</author>
      <nasdaq:tickers>ARRY</nasdaq:tickers>
      <nasdaq:tickers>IDIX</nasdaq:tickers>
      <nasdaq:tickers>INHX</nasdaq:tickers>
      <nasdaq:tickers>KERX</nasdaq:tickers>
      <nasdaq:tickers>SCLN</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/7-biotech-penny-stocks-to-buy-cm49689</feedburner:origLink></item>
  </channel>
</rss>
